QTRX - Quanterix Corp Stock Price, Fair Value and News

$11.74+0.02 (+0.17%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

QTRX Price Action

Last 7 days

2.6%

Last 30 days

-4.4%

Last 90 days

-13.0%

Trailing 12 Months

-51.4%

QTRX RSI Chart

QTRX Valuation

Market Cap

450.6M

Price/Earnings (Trailing)

-11.35

Price/Sales (Trailing)

3.48

EV/EBITDA

-24.77

Price/Free Cashflow

-11.19

QTRX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

QTRX Fundamentals

QTRX Revenue

Revenue (TTM)

129.3M

Rev. Growth (Yr)

10.8%

Rev. Growth (Qtr)

7.22%

QTRX Earnings

Earnings (TTM)

-39.7M

Earnings Growth (Yr)

-56.22%

Earnings Growth (Qtr)

5.95%

QTRX Profitability

Operating Margin

57.42%

EBT Margin

-30.21%

Return on Equity

-11.79%

Return on Assets

-9.66%

Free Cashflow Yield

-8.93%

QTRX Investor Care

Shares Dilution (1Y)

2.20%

Diluted EPS (TTM)

-1.05

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	126.0M	129.3M	0	0
2023	104.4M	112.0M	116.6M	122.4M
2022	112.9M	111.0M	110.0M	105.5M
2021	97.9M	110.1M	106.4M	110.6M
2020	60.1M	59.7M	76.2M	86.4M
2019	42.4M	47.3M	51.7M	56.7M
2018	25.1M	28.5M	33.3M	37.6M
2017	18.9M	20.2M	21.6M	22.9M
2016	0	0	0	17.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

CEO	Dr. Masoud Toloue Ph.D.
WEBSITE	quanterix.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	3200

Quanterix Corp Frequently Asked Questions

What is the ticker symbol for Quanterix Corp? What does QTRX stand for in stocks?

QTRX is the stock ticker symbol of Quanterix Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Quanterix Corp (QTRX)?

As of Fri Nov 22 2024, market cap of Quanterix Corp is 450.57 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of QTRX stock?

You can check QTRX's fair value in chart for subscribers.

Is Quanterix Corp a good stock to buy?

The fair value guage provides a quick view whether QTRX is over valued or under valued. Whether Quanterix Corp is cheap or expensive depends on the assumptions which impact Quanterix Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for QTRX.

What is Quanterix Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Nov 22 2024, QTRX's PE ratio (Price to Earnings) is -11.35 and Price to Sales (PS) ratio is 3.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. QTRX PE ratio will change depending on the future growth rate expectations of investors.